ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 373 filers reported holding ENCOMPASS HEALTH CORP in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,794 | +79.4% | 30 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -90.9% | 30 | -88.1% | 0.00% | -100.0% |
Q2 2022 | $11,000 | -35.3% | 253 | +0.4% | 0.00% | 0.0% |
Q1 2022 | $17,000 | +6.2% | 252 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $16,000 | -11.1% | 252 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $18,000 | -10.0% | 252 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $20,000 | -60.0% | 252 | -57.8% | 0.00% | 0.0% |
Q1 2021 | $50,000 | +150.0% | 597 | +0.2% | 0.00% | 0.0% |
Q4 2020 | $20,000 | -9.1% | 596 | +69.3% | 0.00% | 0.0% |
Q3 2020 | $22,000 | -8.3% | 352 | -14.6% | 0.00% | 0.0% |
Q2 2020 | $24,000 | -4.0% | 412 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $25,000 | -10.7% | 412 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $28,000 | -9.7% | 412 | -18.1% | 0.00% | -50.0% |
Q3 2019 | $31,000 | 0.0% | 503 | +1.4% | 0.00% | 0.0% |
Q2 2019 | $31,000 | +10.7% | 496 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $28,000 | -6.7% | 496 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $30,000 | -6.2% | 496 | +20.4% | 0.00% | 0.0% |
Q3 2018 | $32,000 | +18.5% | 412 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $27,000 | +17.4% | 412 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $23,000 | – | 412 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
RK Capital | 147,290 | $9,431,000 | 4.24% |
HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |